Akums Drugs and Pharmaceuticals Q1 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
498.30
-8.45 (-1.67%)
-8.45 (-1.67%)Volume8.70 K
Updated: Thu 12 Mar, 2026 | 15:29:37
NSE
498.95-8.30 (-1.64%)
-8.30 (-1.64%)Volume1.80 L
Updated: Thu 12 Mar, 2026 | 15:52:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 931.98 | 993.41 | -6.18% | 929.03 | 0.32% |
| Depreciation/ Amortization | 36.92 | 40.00 | -7.69% | 34.06 | 8.38% |
| Operating Income | 92.05 | 62.13 | 48.15% | 90.09 | 2.18% |
| Net Income | 63.48 | 147.62 | -57.00% | 60.17 | 5.49% |
| Other Operating Expenses Total | 137.00 | 138.65 | -1.19% | 122.74 | 11.62% |
| Net Income Before Taxes | 95.65 | 75.14 | 27.30% | 87.48 | 9.34% |
| Total Revenue | 1,024.03 | 1,055.55 | -2.99% | 1,019.11 | 0.48% |
| Selling/ General/ Admin Expenses Total | 176.14 | 183.90 | -4.22% | 176.22 | -0.05% |
| Diluted Normalized EPS | 4.15 | 9.29 | -55.31% | 4.21 | -1.43% |